Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: An open label randomized split dose escalating study

Bone Marrow Transplantation

Volumn 25, Issue 4, 2000, Pages 371-376

  Basara, N ^a,b   Schmetzer, B ^a   Blau, I W ^a   Bischoff, M ^a   Gunzelmann S ^a   Kirsten, D ^a   Fauser, A A ^a  

^a Europ Inst R D Transplant S   (Germany)

^b Clinic for Bone Marrow Transplantation and Hematology/Oncology   (Germany)

Author keywords

Allogeneic stem cell transplant; Lenograstim; Mobilization; Volunteer donors

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; BONE PAIN; CLINICAL TRIAL; DOSE CALCULATION; FEMALE; HEADACHE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SIBLING;

EID: 0034000108     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702168     Document Type: Article

References (25)

1. Dreger P, Suttorp M, Haferlach T et al. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404-1407.
2. Russel NH, Hunter AE. Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 1994; 13: 353-355.
3. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
4. Schmitz N, Bacigalupo A, Labopin M et al on behalf of the European Group for Blood and Marrow Transplantation (EBMT). Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Haematol 1996; 95: 715-723.
5. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
6. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 995-1003.
7. Russel NH, Hunter A, Roger S et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 341: 1482-1483.
8. Lane TA, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275-282.
9. Goldman J. Peripheral blood stem cells for allografting. Blood 1993; 83: 1413-1415.
10. Höglund M, Smedmyr B, Simonsson B et al. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplant 1990; 18: 19-27.
11. Waller TF, Bertz H, Wenger MK et al. Mobilisation of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen. Bone Marrow Transplant 1996; 18: 279-283.
12. Höglund M, Smedmyr B, Bengtsson M et al. Mobilization of CD34 cells by glycosylated and nonglycosylated G-CSF in healthy volunteers - a comparative study. Eur J Haematol 1997; 59: 177-183.
13. + cells in normal donors treated with filgrastim. Transfusion 1997; 37: 507-512.
14. Kreissig C, Kirsch A, Serke S. Characterization and measurement of CD34 expressing hematopoietic cells. J Chemother 1994; 3: 263-289.
15. Fauser AA, Messner HA. Granuloerythropoietic colonies in human bone marrow, peripheral blood and cord blood. Blood 1978; 52: 1243-1248.
16. Steel RGD, Torrie JH. Principles and Procedures of Statistics. McGraw-Hill: New York, 1960.
17. Luider J, Brown C, Selinger S et al. Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection and duration of leukapheresis. J Hematother 1997; 6: 575-580.
18. Tanaka R, Matsudaira T, Aizawa J et al. Characterization of peripheral blood progenitor cells (PBPC) mobilized by filgrastim (rHuG-CSF) in normal volunteers: dose effect relationship for filgrastim with the character of mobilized PBPC. Br J Haematol 1996; 92: 705-803.
19. Arbona C, Prosper F, Benet I et al. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation. Bone Marrow Transplant 1998; 22: 39-45.
20. Weaver CH, Birch R, Greco FA et al. Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. Br J Haematol 1998; 100: 338-347.
21. Dreger P, Haferlach T, Eckslein V et al. G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization and composition of the graft. Br J Haematol 1994; 87: 609-613.
22. Ringden O, Remberger M, Runde V et al. Peripheral blood stem cell (PBSC) transplantation from unrelated donors: a comparison with marrow transplantation. Blood 1999; 94: 455-464.
23. Grigg AP, Roberts AW, Raunow H et al. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilisation and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995; 86: 4437-4445.
24. Weaver CH, Buckner CD, Longin K et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after administration of recombinant human granulocyte colony stimulating factor. Blood 1993; 82: 1981-1984.
25. Geissler K, Peschel C, Niederwieser D et al. Potentiation of granulocyte colony stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3. Blood 1996; 87: 2732-2739.